Extendicare Stock Gross Profit
EXETFDelisted Stock | USD 5.00 0.00 0.00% |
Extendicare fundamentals help investors to digest information that contributes to Extendicare's financial success or failures. It also enables traders to predict the movement of Extendicare Pink Sheet. The fundamental analysis module provides a way to measure Extendicare's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Extendicare pink sheet.
Extendicare |
Extendicare Company Gross Profit Analysis
Extendicare's Gross Profit is the most basic measure of business operational efficiency. It is simply the difference between sales revenue and the cost associated with making a product or providing a service. It is calculated before deducting administrative expenses, taxes, and interest payments.
Current Extendicare Gross Profit | 283.88 M |
Most of Extendicare's fundamental indicators, such as Gross Profit, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Extendicare is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Gross Profit varies significantly from one sector to another and tells an investor how much money a business would have made if it didn't have to pay any overhead expenses such as salary, taxes, or rent.
CompetitionAccording to the company disclosure, Extendicare reported 283.88 M of gross profit. This is 87.34% lower than that of the Health Care Providers & Services sector and significantly higher than that of the Health Care industry. The gross profit for all United States stocks is 98.96% higher than that of the company.
Extendicare Gross Profit Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Extendicare's direct or indirect competition against its Gross Profit to detect undervalued stocks with similar characteristics or determine the pink sheets which would be a good addition to a portfolio. Peer analysis of Extendicare could also be used in its relative valuation, which is a method of valuing Extendicare by comparing valuation metrics of similar companies.Extendicare is currently under evaluation in gross profit category among its peers.
Extendicare Fundamentals
Return On Equity | 0.0018 | ||||
Return On Asset | 0.11 | ||||
Profit Margin | 0.05 % | ||||
Operating Margin | 0.12 % | ||||
Current Valuation | 556.43 M | ||||
Shares Outstanding | 83.94 M | ||||
Shares Owned By Insiders | 13.15 % | ||||
Shares Owned By Institutions | 17.61 % | ||||
Price To Earning | 500.00 X | ||||
Price To Book | 4.28 X | ||||
Price To Sales | 0.32 X | ||||
Revenue | 1.22 B | ||||
Gross Profit | 283.88 M | ||||
EBITDA | 79.64 M | ||||
Net Income | 11.5 M | ||||
Cash And Equivalents | 174.61 M | ||||
Cash Per Share | 2.08 X | ||||
Total Debt | 463.27 M | ||||
Debt To Equity | 2.85 % | ||||
Current Ratio | 1.09 X | ||||
Book Value Per Share | 1.49 X | ||||
Cash Flow From Operations | 63.42 M | ||||
Earnings Per Share | 0.01 X | ||||
Number Of Employees | 31 | ||||
Beta | 1.2 | ||||
Market Capitalization | 419.69 M | ||||
Total Asset | 900.32 M | ||||
Z Score | 1.0 | ||||
Annual Yield | 0.07 % | ||||
Five Year Return | 6.60 % | ||||
Net Asset | 900.32 M | ||||
Last Dividend Paid | 0.48 |
About Extendicare Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Extendicare's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Extendicare using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Extendicare based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Currently Active Assets on Macroaxis
Check out Investing Opportunities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in estimate. You can also try the Bonds Directory module to find actively traded corporate debentures issued by US companies.
Other Consideration for investing in Extendicare Pink Sheet
If you are still planning to invest in Extendicare check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Extendicare's history and understand the potential risks before investing.
Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum | |
Technical Analysis Check basic technical indicators and analysis based on most latest market data | |
Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities | |
Global Markets Map Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes | |
Fundamental Analysis View fundamental data based on most recent published financial statements | |
Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings | |
Price Ceiling Movement Calculate and plot Price Ceiling Movement for different equity instruments | |
Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios | |
Watchlist Optimization Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm |